LOOMIS SAYLES & CO L P - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$30,036,000
-10.6%
532,164
-1.9%
0.04%
-2.4%
Q4 2021$33,612,000
-4.9%
542,316
-2.6%
0.04%
-4.7%
Q3 2021$35,333,000
-24.2%
556,940
-1.5%
0.04%
-23.2%
Q2 2021$46,609,000
+9.8%
565,578
-2.0%
0.06%
+1.8%
Q1 2021$42,452,000
+1.1%
577,032
-0.3%
0.06%
-1.8%
Q4 2020$41,993,000
+51.3%
579,044
-0.6%
0.06%
+40.0%
Q3 2020$27,758,000
+54.2%
582,287
+35.8%
0.04%
+37.9%
Q2 2020$18,003,000428,6440.03%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders